BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, January 28, 2026
Home » Authors » Brady Huggett

Brady Huggett

Articles

ARTICLES

Europeans Eager To Surpass U.S. As Biotechnology Leader

Oct. 21, 2002
By Brady Huggett
LILLE, France - Lille is the fourth largest city in France. It is north of Paris and quite near Brussels, Belgium, all the while being a relatively short train ride from London. Its locale has given the city the honor of being a crossroads. (BioWorld Financial Watch)
Read More

Europeans Eager To Surpass U.S. As Biotechnology Leader

Oct. 21, 2002
By Brady Huggett
LILLE, France - Lille is the fourth largest city in France. It is north of Paris and quite near Brussels, Belgium, all the while being a relatively short train ride from London. Its locale has given the city the honor of being a crossroads. (BioWorld Financial Watch)
Read More

Countries Pitching Platforms To Find Financing, Partners

Oct. 17, 2002
By Brady Huggett

Countries Pitching Platforms To Find Financing, Partners

Oct. 17, 2002
By Brady Huggett

European Officials Seek Unity To Help Challenge U.S. Position

Oct. 16, 2002
By Brady Huggett

European Officials Seek Unity To Help Challenge U.S. Position

Oct. 16, 2002
By Brady Huggett

Genentech Meets Expectations, But Analysts Express Caution

Oct. 11, 2002
By Brady Huggett

Genentech Meets Expectations, But Analysts Express Caution

Oct. 11, 2002
By Brady Huggett

Celera Gets Bayer Compounds To Help Build Clinical Pipeline

Oct. 9, 2002
By Brady Huggett
Knowing that even the most lofty tasks are accomplished one move at a time, Celera Genomics Group made a move pursuing its own lofty goal of becoming a biopharmaceutical company by acquiring a collection of early compounds from Bayer AG. (Bioworld Today)
Read More

Celera Gets Bayer Compounds To Help Build Clinical Pipeline

Oct. 9, 2002
By Brady Huggett
Knowing that even the most lofty tasks are accomplished one move at a time, Celera Genomics Group made a move pursuing its own lofty goal of becoming a biopharmaceutical company by acquiring a collection of early compounds from Bayer AG. (Bioworld Today)
Read More
View All Articles by Brady Huggett

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 26, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 27, 2026.
  • DNA mutations or genetic disorder concept art

    Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

    BioWorld Science

    Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

  • Dice spelling out D-E-A-L-?, yes, no

    Muted and missing M&As: JPM deals absent in 2026

    BioWorld
    For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
  • Brain with stroke illustration

    Brain-derived tau in blood predicts stroke severity and outcome

    BioWorld Science

    Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...

  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing